Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery

Molecular Therapy

Volumn 19, Issue 8, 2011, Pages 1449-1456

  Yamada, Yuma ^a   Furukawa, Ryo ^a   Yasuzaki, Yukari ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CELL NUCLEUS DNA; DEOXYRIBONUCLEASE I; DUAL FUNCTION MITO PORTER; LIPOSOME; MITOCHONDRIAL DNA; NANOCARRIER; OCTAARGININE; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSPORT; CHEMICAL MODIFICATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DNA DETERMINATION; DRUG TARGETING; ENDOSOME; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPOSOMAL DELIVERY; LIVER MITOCHONDRION; MACROMOLECULE; MEMBRANE FUSION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PARTICLE SIZE; PHYSICAL CHEMISTRY; SYNTHESIS;

EID: 79961023252     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.99     Document Type: Article

References (36)

1. Reeve, AK, Krishnan, KJ and Turnbull, D (2008). Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann N Y Acad Sci 1147: 21-29.
2. Chan, DC (2006). Mitochondria: dynamic organelles in disease, aging, and development. Cell 125: 1241-1252. (Pubitemid 43929096)
3. Mukhopadhyay, A and Weiner, H (2007). Delivery of drugs and macromolecules to mitochondria. Adv Drug Deliv Rev 59: 729-738. (Pubitemid 47320812)
4. Schapira, AH (2006). Mitochondrial disease. Lancet 368: 70-82. (Pubitemid 43947206)
5. Wallace, DC (2005). The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 354: 169-180. (Pubitemid 41116698)
6. Yamada, Y and Harashima, H (2008). Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 60: 1439-1462.
7. Clay Montier, LL, Deng, JJ and Bai, Y (2009). Number matters: control of mammalian mitochondrial DNA copy number. J Genet Genomics 36: 125-131.
8. Finsterer, J (2010). Treatment of mitochondrial disorders. Eur J Paediatr Neurol 14: 29-44.
9. Kyriakouli, DS, Boesch, P, Taylor, RW and Lightowlers, RN (2008). Progress and prospects: gene therapy for mitochondrial DNA disease. Gene Ther 15: 1017-1023. (Pubitemid 351927692)
10. Flierl, A, Jackson, C, Cottrell, B, Murdock, D, Seibel, P and Wallace, DC (2003). Targeted delivery of DNA to the mitochondrial compartment via import sequenceconjugated peptide nucleic acid. Mol Ther 7: 550-557. (Pubitemid 36553425)
11. Schatz, G (1996). The protein import system of mitochondria. J Biol Chem 271: 31763-31766. (Pubitemid 26422188)
12. Endo, T, Nakayama, Y and Nakai, M (1995). Avidin fusion protein as a tool to generate a stable translocation intermediate spanning the mitochondrial membranes. J Biochem 118: 753-759.
13. Esaki, M, Kanamori, T, Nishikawa, S and Endo, T (1999). Two distinct mechanisms drive protein translocation across the mitochondrial outer membrane in the late step of the cytochrome b(2) import pathway. Proc Natl Acad Sci USA 96: 11770-11775. (Pubitemid 29502807)
14. Gruhler, A, Ono, H, Guiard, B, Neupert, W and Stuart, RA (1995). A novel intermediate on the import pathway of cytochrome b2 into mitochondria: evidence for conservative sorting. EMBO J 14: 1349-1359.
15. Khalil, IA, Kogure, K, Futaki, S and Harashima, H (2006). High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 281: 3544-3551. (Pubitemid 43845971)
16. Khalil, IA, Kogure, K, Futaki, S, Hama, S, Akita, H, Ueno, M et al. (2007). Octaargininemodified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther 14: 682-689. (Pubitemid 46585628)
17. Yamada, Y, Akita, H, Kamiya, H, Kogure, K, Yamamoto, T, Shinohara, Y et al. (2008). MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta 1778: 423-432.
18. Futaki, S, Suzuki, T, Ohashi, W, Yagami, T, Tanaka, S, Ueda, K et al. (2001). Argininerich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276: 5836-5840.
19. Nakase, I, Niwa, M, Takeuchi, T, Sonomura, K, Kawabata, N, Koike, Y et al. (2004). Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10: 1011-1022. (Pubitemid 39625245)
20. Joliot, A and Prochiantz, A (2004). Transduction peptides: from technology to physiology. Nat Cell Biol 6: 189-196. (Pubitemid 38344356)
21. Schwarze, SR, Ho, A, Vocero-Akbani, A and Dowdy, SF (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572. (Pubitemid 29420581)
22. Yasuzaki, Y, Yamada, Y and Harashima, H (2010). Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem Biophys Res Commun 397: 181-186.
23. Asoh, S, Ohsawa, I, Mori, T, Katsura, K, Hiraide, T, Katayama, Y et al. (2002). Protection against ischemic brain injury by protein therapeutics. Proc Natl Acad Sci USA 99: 17107-17112. (Pubitemid 36034106)
24. Del Gaizo, V and Payne, RM (2003). A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 7: 720-730. (Pubitemid 36790248)
25. Akita, H, Kudo, A, Minoura, A, Yamaguti, M, Khalil, IA, Moriguchi, R et al. (2009). Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials 30: 2940-2949.
26. Futaki, S, Ohashi, W, Suzuki, T, Niwa, M, Tanaka, S, Ueda, K et al. (2001). Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 12: 1005-1011. (Pubitemid 33136872)
27. Suzuki, R, Yamada, Y and Harashima, H (2007). Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device. Biol Pharm Bull 30: 758-762. (Pubitemid 46571006)
28. El-Sayed, A, Khalil, IA, Kogure, K, Futaki, S and Harashima, H (2008). Octaarginineand octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 283: 23450-23461.
29. Kogure, K, Moriguchi, R, Sasaki, K, Ueno, M, Futaki, S and Harashima, H (2004). Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release 98: 317-323. (Pubitemid 38950740)
30. Kogure, K, Akita, H, Yamada, Y and Harashima, H (2008). Multifunctional envelopetype nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev 60: 559-571. (Pubitemid 351215573)
31. Yamada, Y, Kogure, K, Nakamura, Y, Inoue, K, Akita, H, Nagatsugi, F et al. (2005). Development of efficient packaging method of oligodeoxynucleotides by a condensed nano particle in lipid envelope structure. Biol Pharm Bull 28: 1939-1942. (Pubitemid 41437085)
32. Nakamura, Y, Kogure, K, Yamada, Y, Futaki, S and Harashima, H (2006). Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide. J Pharm Pharmacol 58: 431-437.
33. Homhuan, A, Kogure, K, Akaza, H, Futaki, S, Naka, T, Fujita, Y et al. (2007). New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells. J Control Release 120: 60-69. (Pubitemid 46874617)
34. Lee, RJ and Huang, L (1996). Folate-targeted, anionic liposome-entrapped polylysinecondensed DNA for tumor cell-specific gene transfer. J Biol Chem 271: 8481-8487. (Pubitemid 26108687)
35. Akita, H, Ito, R, Khalil, IA, Futaki, S and Harashima, H (2004). Quantitative threedimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol Ther 9: 443-451. (Pubitemid 38404534)
36. Hama, S, Akita, H, Ito, R, Mizuguchi, H, Hayakawa, T and Harashima, H (2006). Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther 13: 786-794.